Yayın:
Bitargeting and ambushing nanotheranostics

dc.contributor.authorRıdvan Say
dc.contributor.authorSay, Rıdvan
dc.contributor.authorLokman Uzun
dc.contributor.authorYılmaz, Filiz
dc.contributor.authorSuzan Yazar
dc.contributor.authorHür, Deniz
dc.contributor.authorAdil Deni̇zli̇
dc.contributor.authorYazar, Suzan
dc.contributor.authorDeniz Hür
dc.contributor.authorErsöz, Arzu
dc.contributor.authorFiliz Yılmaz
dc.contributor.authorArzu Ersöz
dc.contributor.orcid0000-0002-4227-9631
dc.contributor.orcid0000-0002-3971-7725
dc.contributor.orcid0000-0001-7548-5741
dc.contributor.orcid0000-0003-0704-1748
dc.contributor.orcid0000-0002-6138-0460
dc.contributor.orcid0000-0002-2726-2065
dc.date.accessioned2025-11-13T12:24:44Z
dc.date.issued2013-05-13
dc.identifier.doi10.3109/21691401.2013.794359
dc.identifier.endpage145
dc.identifier.issn2169-1401
dc.identifier.issue2
dc.identifier.openalexW1969948010
dc.identifier.pubmed24621078
dc.identifier.scopus2-s2.0-84896120337
dc.identifier.startpage138
dc.identifier.urihttps://hdl.handle.net/11421/9951
dc.identifier.urihttps://doi.org/10.3109/21691401.2013.794359
dc.identifier.volume42
dc.identifier.wos000332863300010
dc.language.isoen
dc.relation.ispartofArtificial Cells Nanomedicine and Biotechnology
dc.rightsopenAccess
dc.subjectDrug delivery
dc.subjectNanotechnology
dc.subjectCancer cell
dc.subjectApoptosis
dc.subjectCytotoxic T cell
dc.subjectCancer
dc.subjectDrug
dc.subjectCancer therapy
dc.subjectMaterials science
dc.subjectCancer research
dc.subjectMedicine
dc.subjectChemistry
dc.subjectPharmacology
dc.subjectIn vitro
dc.subjectInternal medicine
dc.subjectBiochemistry
dc.subject.sdg3
dc.titleBitargeting and ambushing nanotheranostics
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5087716987
local.authorid.openalexA5047216791
local.authorid.openalexA5050802209
local.authorid.openalexA5060261216
local.authorid.openalexA5075172950

Dosyalar

Koleksiyonlar